In, Moreover, the EGFR pathway is overexpressed in HCC cells with acquired resistance to sorafenib, where it acts as the driving force for maintaining HCC cell proliferation under sorafenib (30). This evidence concerns the gene EGFR and hepatocellular carcinoma.